These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24200377)

  • 21. Infected facial tissue fillers: case series and review of the literature.
    Schütz P; Ibrahim HH; Hussain SS; Ali TS; El-Bassuoni K; Thomas J
    J Oral Maxillofac Surg; 2012 Oct; 70(10):2403-12. PubMed ID: 22342250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsurgical modalities to treat the aging face.
    Fitzgerald R; Graivier MH; Kane M; Lorenc ZP; Vleggaar D; Werschler WP; Kenkel JM
    Aesthet Surg J; 2010; 30 Suppl():31S-5S. PubMed ID: 20844299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimally Invasive Facial Cosmetic Procedures.
    Devgan L; Singh P; Durairaj K
    Otolaryngol Clin North Am; 2019 Jun; 52(3):443-459. PubMed ID: 30954270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment for skin rejuvenation and soft-tissue augmentation of the aging face.
    Beer KR
    J Drugs Dermatol; 2011 Feb; 10(2):125-32. PubMed ID: 21283916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Wrinkle fillers in cosmetic facial procedures].
    Jaspers GW; Schepers RH; Pijpe J; Jansma J
    Ned Tijdschr Tandheelkd; 2014 May; 121(5):269-74. PubMed ID: 24881255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facial rejuvenation using neurotoxins and injectable fillers.
    Niamtu J
    Gen Dent; 2013; 61(7):38-46. PubMed ID: 24192733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed-onset complications of facial soft tissue augmentation with permanent fillers in 85 patients.
    Kadouch JA; Kadouch DJ; Fortuin S; van Rozelaar L; Karim RB; Hoekzema R
    Dermatol Surg; 2013 Oct; 39(10):1474-85. PubMed ID: 24090257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cosmetic botulinum toxin: has it replaced more invasive facial procedures?
    Loyo M; Kontis TC
    Facial Plast Surg Clin North Am; 2013 May; 21(2):285-98. PubMed ID: 23731589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel, multistep, combination facial rejuvenation procedure for treatment of the whole face with incobotulinumtoxinA, and two dermal fillers- calcium hydroxylapatite and a monophasic, polydensified hyaluronic acid filler.
    Pavicic T; Few JW; Huber-Vorländer J
    J Drugs Dermatol; 2013 Sep; 12(9):978-84. PubMed ID: 24002143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term complications associated with permanent dermal fillers.
    Kunjur J; Witherow H
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):858-62. PubMed ID: 23962591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications in the Cosmetic Dermatology Patient: A Review and Our Experience (Part 1).
    Vanaman M; Fabi SG; Carruthers J
    Dermatol Surg; 2016 Jan; 42(1):1-11. PubMed ID: 26716709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermal fillers for facial soft tissue augmentation.
    Dastoor SF; Misch CE; Wang HL
    J Oral Implantol; 2007; 33(4):191-204. PubMed ID: 17912960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in facial rejuvenation: Botulinum toxin A. Hyaluronic acid dermal fillers, and combination therapies--consensus recomendations. Editor's Foreword.
    Rohrich RJ
    Plast Reconstr Surg; 2008 May; 121(5 Suppl):1S-2S. PubMed ID: 18449023
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of dermal filler complications.
    Winslow CP
    Facial Plast Surg; 2009 May; 25(2):124-8. PubMed ID: 19415581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foreign body reaction to hyaluronic acid filler injection: in search of an etiology.
    Mamelak AJ; Katz TM; Goldberg LH; Graves JJ; Kaye VN; Friedman PM
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1701-3. PubMed ID: 19807767
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse effects when injecting facial fillers.
    Gladstone HB; Cohen JL
    Semin Cutan Med Surg; 2007 Mar; 26(1):34-9. PubMed ID: 17349561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facial Filler Complications.
    Woodward J; Khan T; Martin J
    Facial Plast Surg Clin North Am; 2015 Nov; 23(4):447-58. PubMed ID: 26505541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injectable fillers for facial rejuvenation: a review.
    Buck DW; Alam M; Kim JY
    J Plast Reconstr Aesthet Surg; 2009 Jan; 62(1):11-8. PubMed ID: 18951862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.